Galmed Pharmaceuticals Ltd
NASDAQ:GLMD

Watchlist Manager
Galmed Pharmaceuticals Ltd Logo
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
Watchlist
Price: 0.8541 USD -2.94%
Market Cap: 4.7m USD

Intrinsic Value

GLMD doesn't have a meaningful market cap.

The intrinsic value of one GLMD stock under the Base Case scenario is 3.7672 USD. Compared to the current market price of 0.8541 USD, Galmed Pharmaceuticals Ltd is Undervalued by 77%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GLMD Intrinsic Value
3.7672 USD
Undervaluation 77%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Galmed Pharmaceuticals Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about GLMD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GLMD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Galmed Pharmaceuticals Ltd.

Explain Valuation
Compare GLMD to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GLMD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Galmed Pharmaceuticals Ltd

Current Assets 19.7m
Cash & Short-Term Investments 19.1m
Receivables 549k
Other Current Assets 124k
Non-Current Assets 1.9m
Long-Term Investments 1.6m
Other Non-Current Assets 267k
Current Liabilities 2.5m
Accounts Payable 1.7m
Other Current Liabilities 798k
Efficiency

Free Cash Flow Analysis
Galmed Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Galmed Pharmaceuticals Ltd

Revenue
0 USD
Operating Expenses
-8.8m USD
Operating Income
-8.8m USD
Other Expenses
83k USD
Net Income
-8.7m USD
Fundamental Scores

GLMD Profitability Score
Profitability Due Diligence

Galmed Pharmaceuticals Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
41/100
Profitability
Score

Galmed Pharmaceuticals Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

GLMD Solvency Score
Solvency Due Diligence

Galmed Pharmaceuticals Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Galmed Pharmaceuticals Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GLMD Price Targets Summary
Galmed Pharmaceuticals Ltd

There are no price targets for GLMD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Galmed Pharmaceuticals Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for GLMD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one GLMD stock?

The intrinsic value of one GLMD stock under the Base Case scenario is 3.7672 USD.

Is GLMD stock undervalued or overvalued?

Compared to the current market price of 0.8541 USD, Galmed Pharmaceuticals Ltd is Undervalued by 77%.

Back to Top